Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 3
1949 2
1950 1
1951 1
1952 1
1956 1
1957 2
1958 1
1959 2
1960 1
1974 1
1975 3
1990 5
1991 2
1993 1
1997 1
2002 1
2003 1
2004 2
2005 2
2006 1
2008 5
2009 6
2010 8
2011 7
2012 8
2013 8
2014 6
2015 8
2016 3
2017 4
2018 6
2019 4
2020 4
2021 8
2022 9
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Silent corticotroph adenomas.
Ben-Shlomo A, Cooper O. Ben-Shlomo A, et al. Among authors: cooper o. Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Pituitary. 2018. PMID: 29344907 Review.
Silent corticotroph adenomas.
Cooper O. Cooper O. Pituitary. 2015 Apr;18(2):225-31. doi: 10.1007/s11102-014-0624-3. Pituitary. 2015. PMID: 25534889 Free PMC article. Review.
Dopamine Agonists for Pituitary Adenomas.
Cooper O, Greenman Y. Cooper O, et al. Front Endocrinol (Lausanne). 2018 Aug 21;9:469. doi: 10.3389/fendo.2018.00469. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30186234 Free PMC article. Review.
Editorial: Targeted Therapy for Pituitary Adenomas.
Araki T, Cooper O, Fukuoka H. Araki T, et al. Among authors: cooper o. Front Endocrinol (Lausanne). 2019 Jun 4;10:358. doi: 10.3389/fendo.2019.00358. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31214126 Free PMC article. No abstract available.
Frontline therapy of ovarian cancer: trials and tribulations.
Volpe J, Filipi JG, Cooper OR, Penson RT. Volpe J, et al. Among authors: cooper or. Curr Opin Obstet Gynecol. 2018 Feb;30(1):1-6. doi: 10.1097/GCO.0000000000000434. Curr Opin Obstet Gynecol. 2018. PMID: 29251676 Review.
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas.
Cooper O, Bonert VS, Rudnick J, Pressman BD, Lo J, Salvatori R, Yuen KCJ, Fleseriu M, Melmed S. Cooper O, et al. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e917-e925. doi: 10.1210/clinem/dgaa805. J Clin Endocrinol Metab. 2021. PMID: 33150390 Free PMC article. Clinical Trial.
Subclinical hyperfunctioning pituitary adenomas: the silent tumors.
Cooper O, Melmed S. Cooper O, et al. Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22863387 Free PMC article. Review.
Ectopic acromegaly due to growth hormone releasing hormone.
Ghazi AA, Amirbaigloo A, Dezfooli AA, Saadat N, Ghazi S, Pourafkari M, Tirgari F, Dhall D, Bannykh S, Melmed S, Cooper O. Ghazi AA, et al. Among authors: cooper o. Endocrine. 2013 Apr;43(2):293-302. doi: 10.1007/s12020-012-9790-0. Epub 2012 Sep 15. Endocrine. 2013. PMID: 22983831 Free PMC article. Review.
124 results